ViaCyte is a series c plus startup based in United States. 1 investor tracked on Brouky Intelligence. Status: zombie. Data sourced from Brouky Intelligence.
About
ViaCyte is a regenerative medicine company focused on developing cell replacement therapies for diabetes.
Stage
series-c-plus
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky